Skip to main content
. 2013 Oct 1;13:23. doi: 10.1186/1472-6890-13-23

Table 8.

VRK2 as prognostic index in astrocytomas

Risk group
No. patients %
Hazard ratio (95% C.I.)
Median survival (months) (95% C.I.)
Pvalue
Survival rate
  1-year 2-year 3-year
Low-risk
28 (37.8%)
1
15.7 (12.3 – 19.0)
<0.001
67.9%
25.5%
21.3%
High-risk 46 (62.2%) 2.64 (1.53 – 4.55) 9.8 (7.9 – 11.8)   39.8% 7.0% 0.0%